Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen (Q44612711)

4 December 2017

title

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen (English)

1 reference

4 December 2017

1 reference

15

Didier Blaise

1 reference

4 December 2017

10

Christian Chabannon

1 reference

4 December 2017

Catherine Faucher

1

1 reference

4 December 2017

Mohamad Mohty

2

1 reference

4 December 2017

Norbert Vey

3

1 reference

4 December 2017

Béatrice Gaugler

4

1 reference

4 December 2017

Karin Bilger

5

1 reference

4 December 2017

Marie-Joelle Moziconnacci

6

1 reference

4 December 2017

Anne-Marie Stoppa

7

1 reference

4 December 2017

Diane Coso

8

1 reference

4 December 2017

Patrick Ladaique

9

1 reference

4 December 2017

Denis Reviron

11

1 reference

4 December 2017

Dominique Maraninchi

12

1 reference

4 December 2017

Jean-Albert Gastaut

13

1 reference

4 December 2017

Daniel Olive

14

1 reference

4 December 2017

publication date

1 October 2003

1 reference

4 December 2017

published in

Experimental Hematology

1 reference

4 December 2017

volume

31

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

873-880

1 reference

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

A randomised study of allogeneic transplantation with stem cells from blood or bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900194-2

7 January 2021

10.1016/S0301-472X(03)00194-2

Identifiers

DOI

1 reference

4 December 2017

1 reference